Azithromycin is an azalide antibiotic, and its mechanism of action is to bind to the 50s ribosome subunit of sensitive microorganisms, thereby interfering with their protein synthesis (without affecting nucleic acid synthesis). It is effective against a variety of pathogenic bacteria, including Gram-positive aerobic microorganisms, Gram-negative aerobic microorganisms, and avian intracellular mycobacterium complex.

This product is an H2 receptor antagonist. It replaces the imidazole ring of cimetidine with a furan ring. It has a higher selectivity for H2 receptors and can significantly inhibit the basal and nocturnal gastric acid secretion of normal people and ulcer patients, as well as the gastric acid secretion caused by pentagastrin, histamine and meals. Its potency in inhibiting gastric acid secretion is 5 to 12 times that of cimetidine in terms of moles. Intravenous injection of this product can reduce gastric acid secretion by 90%; it has a certain inhibitory effect on the secretion of pepsinogen. It has a protective effect on experimental gastric mucosal damage and acute ulcers. It has no effect on the secretion of gastrin and sex hormones.

Choleretic, anti-inflammatory, anti-hepatic fatty degeneration

Choleretic, anti-inflammatory, anti-stone

Anti-inflammatory, anti-hepatic fatty degeneration

Promoting bile secretion and preventing stones

Anti-inflammatory, anti-hepatic fatty degeneration

Choleretic, anti-inflammatory

Anti-hepatic steatosis

Choleretic, anti-inflammatory, anti-stone

This product is a diphenylpiperazine calcium channel blocker with selective cerebral vasodilation.

Extract from the above information